Literature DB >> 9814974

Sphingosylphosphorylcholine stimulates mitogen-activated protein kinase via a Ca2+-dependent pathway.

T Y Chin1, S H Chueh.   

Abstract

In cultured porcine aortic smooth muscle cells, sphingosylphosphorylcholine (SPC), ATP, or bradykinin (BK) induced a rapid dose-dependent increase in the cytosolic Ca2+ concentration ([Ca2+]i) and also stimulated inositol 1,4,5-trisphosphate (IP3) generation. Pretreatment of cells with pertussis toxin blocked the SPC-induced IP3 generation and [Ca2+]i increase but had no effect on the action of ATP or BK. In addition, SPC stimulated the mitogen-activated protein kinase (MAPK) and increased DNA synthesis, whereas neither ATP nor BK produced such effects. Both the SPC-induced MAPK activation and DNA synthesis were pertussis toxin sensitive. SPC-induced MAPK activation was blocked by treatment of cells with the phospholipase C inhibitor, U-73122, or the intracellular Ca2+-ATPase inhibitor, thapsigargin, but not by removal of extracellular Ca2+. Lysophosphatidic acid induced cellular responses similar to SPC in a pertussis toxin-sensitive manner in terms of [Ca2+]i increase, IP3 generation, MAPK activation, and DNA synthesis. Platelet-derived growth factor (PDGF) also induced a [Ca2+]i increase, MAPK activation, and DNA synthesis in the same cells; however, the PDGF-induced MAPK activation was not sensitive to pertussis toxin and changes in [Ca2+]i. SPC-induced MAPK activation was inhibited by pretreatment of cells with staurosporine, W-7, or calmidazolium. Our results suggest that, in porcine aortic smooth muscle cells, MAPK is not activated by the increase in [Ca2+]i unless a pertussis toxin-sensitive G protein is simultaneously stimulated, indicating the role of Ca2+ in pertussis toxin-sensitive G protein-mediated MAPK activation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9814974     DOI: 10.1152/ajpcell.1998.275.5.C1255

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Distinct Ca(2+) signalling mechanisms induced by ATP and sphingosylphosphorylcholine in porcine aortic smooth muscle cells.

Authors:  T Y Chin; S H Chueh
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

2.  Store depletion-induced calcium influx in rat cerebellar astrocytes.

Authors:  Kuo-Jung Lo; Hsiang-Ning Luk; Ting-Yu Chin; Sheau-Huei Chueh
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 3.  Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine.

Authors:  Denise G Hemmings
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04       Impact factor: 3.000

Review 4.  Emerging roles of sphingosylphosphorylcholine in modulating cardiovascular functions and diseases.

Authors:  Di Ge; Hong-Wei Yue; Hong-Hong Liu; Jing Zhao
Journal:  Acta Pharmacol Sin       Date:  2018-07-26       Impact factor: 6.150

Review 5.  Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites.

Authors:  Astrid E Alewijnse; Stephan L M Peters; Martin C Michel
Journal:  Br J Pharmacol       Date:  2004-10-25       Impact factor: 8.739

6.  Augmented sphingosylphosphorylcholine-induced Ca2+-sensitization of mesenteric artery contraction in spontaneously hypertensive rat.

Authors:  Sung-Kyung Ryu; Duck Sun Ahn; Young-Eun Cho; Soo-Kyung Choi; Young-Hwan Kim; Kathleen G Morgan; Young-Ho Lee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-07       Impact factor: 3.000

7.  Re-evaluation of primary structure, topology, and localization of Scamper, a putative intracellular Ca2+ channel activated by sphingosylphosphocholine.

Authors:  Raphaela Schnurbus; Davide de Pietri Tonelli; Fabio Grohovaz; Daniele Zacchetti
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

8.  A novel sphingosylphosphorylcholine and sphingosine-1-phosphate receptor 1 antagonist, KRO-105714, for alleviating atopic dermatitis.

Authors:  Sae-Bom Yoon; Chang Hoon Lee; Hyun Young Kim; Daeyoung Jeong; Moon Kook Jeon; Sun-A Cho; Kwangmi Kim; Taeho Lee; Jung Yoon Yang; Young-Dae Gong; Heeyeong Cho
Journal:  J Inflamm (Lond)       Date:  2020-05-29       Impact factor: 4.981

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.